(combined hormonal therapy): the use of more than one variety of hormone therapy; especially the use of LHRH analogs (e.g., Lupron®, Zoladex®) to block the production of testosterone by the testes, plus antiandrogens (e.g., Casodex® (bicalutamide), Eulexin® (flutamide), Anandron® (nilutamide), or Androcur® (cyproterone)) to compete with DHT and with T (testosterone) for cell androgen receptors thereby depriving cancer cells of DHT and T needed for growth; also referred to as CHB, MAB, TAB; the preferred term is ADT